Welcome to our dedicated page for Zimmer Biomet news (Ticker: ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet stock.
Zimmer Biomet Holdings, Inc. reports developments across its global medical technology business, including orthopedic reconstructive implants, surgical products, and integrated digital and robotic technologies that use data, analytics and artificial intelligence. Company updates commonly cover quarterly results and guidance, dividend actions, health care conference appearances, executive leadership changes, and clinical or operational data presented at orthopedic meetings.
Product-focused announcements describe musculoskeletal care technologies such as Oxford Cementless Partial Knee, Persona OsseoTi Keel Tibia, and HAMMR Automated Hip Impaction System, alongside broader portfolio themes in knees, hips, smart implants, robotics, AI and medical education.
Zimmer Biomet Holdings, Inc. (ZBH) will host its second quarter earnings conference call on August 4, 2020, at 8:30 a.m. ET. A news release detailing the quarterly results will be available at 6:30 a.m. ET on the same day. The call can be accessed via Zimmer Biomet's Investor Relations website, and a digital recording will be available from August 4 to October 4, 2020. For U.S. and Canada participants, the call can be joined by dialing (888) 312-9837 with conference ID 7278985.
Zimmer Biomet Holdings (NYSE: ZBH) introduces new features to its mymobility platform with Apple Watch, enhancing remote care management for joint replacement patients. The upgrade includes gait quality metrics, which provide real-time patient data and improve post-operative care management. These updates aim to optimize patient experience and reduce in-office visits. The new features will be showcased at the virtual WWDC 2020 from June 22 to 26, 2020, and will be available later this year. This digital transformation prioritizes effective patient management in the current healthcare landscape.